Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00226356 · ClinicalTrials.gov registry record · Phase 4
Natural Supplements for Unipolar Depression
A Phase 4 study, sponsored by Cambridge Health Alliance.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00226356 is a Phase 4 study that has completed, run by Cambridge Health Alliance. The registered enrollment target is 20 participants.
The verdict
NCT00226356, a Phase 4 study, has completed, sponsored by Cambridge Health Alliance.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression.
Interventions
- DRUG Supplements of L-methionine, betaine and folate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-12 |
| Est. Completion | 2008-09-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00226356
The ClinicalTrials.gov registry entry for NCT00226356 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cambridge Health Alliance, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Supplements of L-methionine, betaine and folate is the first listed.
NCT00226356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00226356 about?
NCT00226356 is a clinical study titled "Natural Supplements for Unipolar Depression". This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression.
What is the current status of trial NCT00226356?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-12. Estimated completion is 2008-09-17.
What interventions are being tested in trial NCT00226356?
The interventions under investigation include: Supplements of L-methionine, betaine and folate (DRUG).
Who is sponsoring clinical trial NCT00226356?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.